We are live on ! Find out more
BC

Barrett & Company Portfolio holdings

AUM $357M
1-Year Est. Return 22.45%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+22.45%
3 Year Est. Return
+74.84%
5 Year Est. Return
10 Year Est. Return
AUM
$172M
AUM Growth
+$14.6M
Cap. Flow
+$4.89M
Cap. Flow %
2.84%
Top 10 Hldgs %
34%
Holding
621
New
25
Increased
146
Reduced
71
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 9.22%
2 Financials 6.33%
3 Healthcare 4.62%
4 Industrials 4.27%
5 Consumer Discretionary 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWD icon
26
iShares Russell 1000 Value ETF
IWD
$82.2B
$1.38M 0.8%
8,753
+251
+3% +$38.4K
PG icon
27
Procter & Gamble
PG
$336B
$1.36M 0.79%
8,936
+406
+5% +$61.2K
VB icon
28
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$1.34M 0.78%
6,760
+150
+2% +$28.3K
LMBS icon
29
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.35B
$1.27M 0.74%
26,651
-224
-0.8% -$10.7K
VIG icon
30
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.15M 0.67%
7,074
+359
+5% +$56.2K
CALF icon
31
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.68B
$1.13M 0.66%
27,799
+6,161
+28% +$234K
CVX icon
32
Chevron
CVX
$392B
$997K 0.58%
6,338
+150
+2% +$24K
IBDP
33
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$988K 0.57%
40,144
+1,727
+4% +$42.5K
META icon
34
Meta Platforms (Facebook)
META
$1.42T
$977K 0.57%
3,405
+360
+12% +$88.8K
RSP icon
35
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$972K 0.56%
6,499
-374
-5% -$53.9K
JPM icon
36
JPMorgan Chase
JPM
$935B
$965K 0.56%
6,632
+492
+8% +$67.7K
IBDQ
37
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$921K 0.53%
37,770
-15,490
-29% -$379K
IBDO
38
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$913K 0.53%
36,111
+111
+0.3% +$2.8K
PEY icon
39
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.13B
$888K 0.52%
46,208
+151
+0.3% +$2.91K
BSV icon
40
Vanguard Short-Term Bond ETF
BSV
$44.7B
$878K 0.51%
11,620
-44
-0.4% -$3.35K
BA icon
41
Boeing
BA
$171B
$864K 0.5%
4,092
MET icon
42
MetLife
MET
$61.9B
$842K 0.49%
14,895
+105
+0.7% +$5.83K
TXT icon
43
Textron
TXT
$14.7B
$814K 0.47%
12,030
CVS icon
44
CVS Health
CVS
$133B
$807K 0.47%
11,679
+314
+3% +$22.3K
KNG icon
45
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.4B
$798K 0.46%
15,097
+1,000
+7% +$51.6K
MRK icon
46
Merck
MRK
$322B
$787K 0.46%
6,824
SHY icon
47
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$782K 0.45%
9,650
BMY icon
48
Bristol-Myers Squibb
BMY
$133B
$766K 0.44%
11,984
-1,787
-13% -$120K
VWO icon
49
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$754K 0.44%
18,529
+304
+2% +$12.3K
SCHB icon
50
Schwab US Broad Market ETF
SCHB
$43.2B
$728K 0.42%
42,234
+81
+0.2% +$1.32K

Similar funds

Barrett & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Barrett & Company held 621 positions worth $172M, up 9.2% from $158M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barrett & Company's Q2 2023 filing shows 25 new, 146 increased, 71 reduced and 8 closed positions. Its largest new stake was Capital Group Dividend Value ETF: 6,050 shares worth $164K. The largest sale was iShares iBonds Dec 2025 Term Corporate ETF, an estimated $379K.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 6.5% a quarter earlier, followed by Financials and Healthcare.

  • Barrett & Company's largest Q2 2023 buy was Capital Group Dividend Value ETF: 6,050 shares worth $164K.
  • Barrett & Company added most to Tesla in Q2 2023, an estimated $1.13M increase.
  • Barrett & Company's biggest Q2 2023 reduction was iShares iBonds Dec 2025 Term Corporate ETF, cutting an estimated $379K.
  • Barrett & Company fully exited Immunogen Inc in Q2 2023, selling an estimated $23K.
  • Barrett & Company's ten largest holdings make up 34% of its $172M portfolio in Q2 2023.
  • Barrett & Company opened 25 new positions and closed 8 in Q2 2023.
  • Barrett & Company's portfolio value rose 9.2% quarter-over-quarter to $172M.

Based on Barrett & Company's 13F filing for Q2 2023, filed 27 Jul 2023.